This study assessed the extent to which high fat diet (HFD)-induced β-amyloid accumulation and cognitive decline in APP/PSEN1 mice are reversible through control of fat intake. Ten months of HFD (60% calories from fat) led to significant deficits in a 2-trial Y maze task, and nest building assay, and decreased voluntary locomotor activity. The HFD induced an inflammatory response, indicated by increased expression of several inflammatory markers. Substituting a low fat diet led to pronounced weight loss and correction of glucose intolerance, decreases in the inflammatory response, and improved performance on behavioral tasks in both wild-type and APP/PSEN1 transgenic mice. Insoluble β-amyloid levels, and extent of tau phosphorylation were also lower following dietary reversal in APP/PSEN1 mice compared to high fat-fed animals, indicating that the inflammatory response may have contributed to key pathogenic pathways in the Alzheimer's disease model. The data suggest that weight loss can be a vital strategy for cognitive protection, but also highlight potential mechanisms for intervention when sustained weight loss is not possible.
Introduction
Obesity and Alzheimer's disease both have alarmingly high prevalence in Western societies (Alzheimer's-Association, 2015; Ogden et al., 2014) , and both are associated with cognitive decline and diabetes (Beydoun et al., 2008; Gustafson et al., 2003; Profenno et al., 2010; Whitmer et al., 2007) . High fat diets (HFD) are thought to contribute directly to several of the key facets of Alzheimer's disease, including increased accumulation of β-amyloid (Aβ), hyperphosphorylation of tau, and an inflammatory state in peripheral organs and brain (including astrocyte and microglial activation) (Levin-Allerhand et al., 2002; Puig et al., 2012; Ramos-Rodriguez et al., 2014; Shie et al., 2002; Zhang et al., 2016) . Altered Aβ levels are not universally found (Knight et al., 2014; Peng et al., 2014; Studzinski et al., 2009) , and may depend on the mouse model used, the level and type of dietary fat, and the duration of treatments. Tau phosphorylation has been studied less frequently, in part because of the weighting toward Aβ pathology in the most commonly-used mouse models of Alzheimer's disease. Each of these pathological factors may contribute to cognitive factors individually, and also via changes to blood brain barrier (BBB) permeability. MRI imaging techniques have indicated BBB breakdown in hippocampus may be an early event in the Alzheimer's disease pathological cascade (Montagne et al., 2015; van de Haar et al., 2016b) . BBB leakage is also directly increased by HFD (Loffler et al., 2016; Ramos-Rodriguez et al., 2014; Takechi et al., 2013) , and long-term feeding with both saturated fatty acids and high cholesterol appear to exacerbate the effects of aging on BBB permeability (Takechi et al., 2013) .
Studies that included measures of cognition also demonstrate that HFD induces deficits in learning and memory, although experimental design strongly impacts the severity of deficits, and whether changes are observed in both control animals and the disease model (Knight et al., 2014; Pistell et al., 2010; Ramos-Rodriguez et al., 2014; Yeh et al., 2015) . Negative effects on cognitive ability are found across several behavioral tasks, despite the challenges in testing in these populations, which vary dramatically in body size and adiposity. Now that the links between HFD, inflammatory response and cognitive decline have been established, in both Aβ-positive and -negative Abbreviations: HFD, high fat diet; LFD, low fat diet; HFD to LFD, REV, reversal diet; Aβ, β-amyloid; APP, amyloid Precursor Protein; PSEN1, presenilin 1; RAGE, RECEPTOR for Advanced Glycation End Products; AGE, Advanced Glycation End Products; EZM, elevated zero maze; GTT, glucose tolerance test; TNF-α, tumor necrosis factor-alpha; IL: IL-1b, IL-6, IL-10, inter-leukin; ELISA, enzyme-linked immunosorbent assay; GFAP, glial fibrillary acidic protein; MDA, Malondialdehyde.
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